Neal Farber of NeuroHealing Pharmaceuticals joined us for World Orphan Drug Congress USA 2014 to present about ‘ NH001–Cognitive Recovery After Severe Brain Injury’ .
Download his presentation now to learn about:
- Medical rationale for use of dopaminergics for recovering consciousness in TBI
- Rationale for use of NH001
- NH001-1 Pilot Study Results
- NH001-2 Study Design
…and much more!
Get your copy here!
To find out more about how NH001 can provide cognitive recovery after severe brain injury , attend World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.